Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment. | Front Med (Lausanne) | 2022 | 35721061 | PubTator, text mining | PubMed |
| Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis. | Ren Fail | 2022 | 35713363 | PubTator, text mining | PubMed |
| Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae. | Front Immunol | 2022 | 35711467 | PubTator, text mining | PubMed |
| Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment. | Haematologica | 2022 | 35708136 | PubTator, text mining | PubMed |
| A proteogenomic signature of age-related macular degeneration in blood. | Nat Commun | 2022 | 35697682 | PubTator, text mining | PubMed |
| Competitive inhibition of the classical complement pathway using exogenous single-chain C1q recognition proteins. | J Biol Chem | 2022 | 35690144 | PubTator, text mining | PubMed |
| Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. | Blood | 2022 | 35687757 | PubTator, text mining | PubMed |
| Biophysical Characterization of the Oligomeric States of Recombinant Immunoglobulins Type-M and Their C1q-Binding Kinetics by Biolayer Interferometry. | Front Bioeng Biotechnol | 2022 | 35685087 | PubTator, text mining | PubMed |
| A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins. | Mucosal Immunol | 2022 | 35672453 | PubTator, text mining | PubMed |
| Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis. | Front Immunol | 2022 | 35669782 | PubTator, text mining | PubMed |
| Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance. | Blood Adv | 2022 | 35667091 | PubTator, text mining | PubMed |
| Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma. | Front Oncol | 2022 | 35664769 | PubTator, text mining | PubMed |
| The yin and the yang of early classical pathway complement disorders. | Clin Exp Immunol | 2022 | 35648651 | PubTator, text mining | PubMed |
| Altered mRNAs Profiles in the Testis of Patients With "Secondary Idiopathic Non-Obstructive Azoospermia". | Front Cell Dev Biol | 2022 | 35646930 | PubTator, text mining | PubMed |
| Using plasma proteomics to investigate viral infections of the central nervous system including patients with HIV-associated neurocognitive disorders. | J Neurovirol | 2022 | 35639337 | PubTator, text mining | PubMed |
| Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients. | Front Immunol | 2022 | 35634287 | PubTator, text mining | PubMed |
| Development of New Drugs for Autoimmune Hemolytic Anemia. | Pharmaceutics | 2022 | 35631621 | PubTator, text mining | PubMed |
| A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets. | J Clin Med | 2022 | 35628982 | PubTator, text mining | PubMed |
| Proteomics Studies in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | 35628864 | PubTator, text mining | PubMed |
| Current Insights on the Impact of Proteomics in Respiratory Allergies. | Int J Mol Sci | 2022 | 35628512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=37